CDH11 and rheumatoid arthritis: The phenotypes of aggressive RA-FLSs can have tumor-like attributes in terms of excessive proliferation, invasion, and migration capacities (10, 20), suggesting that suppressing pPDGFRαβ expression and promoting CDH11 expression in FLSs could be an effective treatment strategy for RA.